Privia Health Group, Inc. · Health Services

PRVA

Low riskNext report: Around Nov 5 (est.)

View price ↗

The short version

A profitable company with growing sales.

Going well

Sales up 21% in the latest quarter vs a year ago
Profitable
Sales up 22% last year

Watch out for

Share count growing 5.2% a year

Money moves

No insider buying or selling in the last 30 days
Institutions cut 1.1% from their holdings in the quarter ending June 2026 (156 bought, 135 sold)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$22.15-1.2% that day

Company value: $2.8B; Share price times all shares
Price vs profit (P/E): 105.5x; You pay about $105 for each $1 of yearly profit
Price vs sales: 1.2x; Company value is 1.2 times a year of sales
Cash vs value: 15%; Cash as a share of company value

From PRVA's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$632.6M+21% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $2.4B, up 24% from the 12 months before. Over 5 years, sales grew about 21% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of PRVA. Starting points are the company's recent numbers.

Sales growth+24% a yearRecently: +24% a yearProfit margin1%Last 12 months: 1.2%P/E at the end40xToday: 105.5x. Many steady companies trade at 12x to 25xShare count change+5% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$6.9B

Profit in 5 years$69M

Price these guesses point to$16.96-23% vs $22.15 todayAbout -5.2% a year, before dividends

What today's price needs: with a 1% margin and a 40x P/E, sales would have to grow about 31% a year for 5 years just to match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

2/6Weak

MissReturn on equity 15%+Earns a lot on the money owners have in the business.3.3%
PassDebt under half of equityNot relying on borrowed money.No debt reported
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.1.1%
MissProfitable every yearSteady profits, not one good year.5 of 7 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$163.4M
MissShare count not growingNot diluting owners. Falling means buybacks.+16.4% in 3 years

Revenue: $2.1B; +22.3% vs prior year
5-year growth: +21.0%/yr; revenue, per year
Total debt: None; 0.00x equity
Current ratio: 1.60x; short-term assets / bills due

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: gross margin 40%+. A checklist is a starting point for research, not a verdict.